TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 10, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 5
- 0 vs. Q4 2021
- Portfolio value
- $273.0M
- −$74.8M (−21.5%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $146.8M | 53.8% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $55.4M | 20.3% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 1,419,900 | $36.2M | 13.3% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 6,758,204 | $19.6M | 7.2% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $15.0M | 5.5% | 00.0% | Unchanged | History |